These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 32681007
1. Decreasing undesirable absorbed radiation to the intestine after administration of radium-223 dichloride for treatment of bone metastases. Ogawa K, Higashi T, Mishiro K, Wakabayashi H, Shiba K, Odani A, Kinuya S. Sci Rep; 2020 Jul 17; 10(1):11917. PubMed ID: 32681007 [Abstract] [Full Text] [Related]
2. Complexes of myo-inositol-hexakisphosphate (InsP6) with zinc or lanthanum to enhance excretion of radioactive strontium from the body. Ogawa K, Aoki M, Kadono S, Odani A. PLoS One; 2018 Jul 17; 13(4):e0195067. PubMed ID: 29614122 [Abstract] [Full Text] [Related]
3. [223Ra] RaCl2 nanomicelles showed potent effect against osteosarcoma: targeted alpha therapy in the nanotechnology era. Yang Y, Alencar LMR, Pijeira MSO, Batista BDS, França ARS, Rates ERD, Lima RC, Gemini-Piperni S, Santos-Oliveira R. Drug Deliv; 2022 Dec 17; 29(1):186-191. PubMed ID: 35191342 [Abstract] [Full Text] [Related]
6. Use of Radium-223 Dichloride in Patients With Osteonecrosis of the Jaw Induced by Zoledronic Acid: Report of 2 Cases. Dionisi V, Bellarosa C, Cardano R, Rizzini EL, Ghedini P, Morganti AG, Fanti S, Monari F. Clin Genitourin Cancer; 2019 Jun 17; 17(3):e612-e617. PubMed ID: 30956096 [No Abstract] [Full Text] [Related]
9. Micellar solution of [223Ra]RaCl2: Reaching renal excretion, potent efficacy in osteoblastic osteosarcoma in PDX model, biochemistry alterations and pharmacokinetics. Pijeira MSO, Gomes-da-Silva NC, Ricci-Junior E, Alencar LMR, İlem-Özdemir D, Cavalcanti ADS, Machado DE, Perini JA, Santos-Oliveira R. Int J Pharm; 2024 Mar 05; 652():123765. PubMed ID: 38195032 [Abstract] [Full Text] [Related]
10. The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates. Jiang W, Ulmert D, Simons BW, Abou DS, Thorek DLJ. Nucl Med Biol; 2018 Mar 05; 62-63():1-8. PubMed ID: 29800797 [Abstract] [Full Text] [Related]
12. Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why. Gallicchio R, Mastrangelo PA, Nardelli A, Mainenti PP, Colasurdo AP, Landriscina M, Guglielmi G, Storto G. Tumori; 2019 Oct 05; 105(5):367-377. PubMed ID: 31096849 [Abstract] [Full Text] [Related]
16. S-values for radium-223 and absorbed doses estimates for 223RACL2 using three computational phantoms. Silva CCO, da Silva AX, Braz D, Lima LFC, Segars WP, de Sá LV. Appl Radiat Isot; 2022 Nov 05; 189():110387. PubMed ID: 36137481 [Abstract] [Full Text] [Related]